List of exosome patents

List of exosome patents

List of home safety patents

List of semantic web patents

List of patents in the Renewable energy industry

Companies in the D2C industry

List of funding rounds for Alnylam Pharmaceuticals

Patents where

Current Assignee

Industry

is

	Name	Description	Patent Applicant	Current Assignee	Inventor	Patent Jurisdiction	Patent Number	Date of Patent
	‌ US Patent 11529370 Use of composition comprising stem cell-derived exosome as effective ingredient in strengthening skin barrier and improving skin barrier function	Patent 11529370 was granted and assigned to ExoCoBio on December, 2022 by the United States Patent and Trademark Office.	ExoCoBio	ExoCoBio		United States Patent and Trademark Office	11529370	December 20, 2022
	‌ US Patent 11446333 Use of composition comprising stem cell-derived exosome as effective ingredient for suppression or alleviation of pruritus		ExoCoBio	ExoCoBio		United States Patent and Trademark Office	11446333	September 20, 2022
	‌ US Patent 11529306 Lyophilized formulation of stem cell-derived exosomes and anti-inflammatory composition including the same as active ingredient		ExoCoBio	ExoCoBio		United States Patent and Trademark Office	11529306	December 20, 2022
	‌ US Patent 11337419 Method for lyophilizing exosome		ExoCoBio	ExoCoBio		United States Patent and Trademark Office	11337419	May 24, 2022
	‌ US Patent 11534392 Cosmetic composition comprising exosomes derived from galactomyces as active ingredient	Patent 11534392 was granted and assigned to ExoCoBio on December, 2022 by the United States Patent and Trademark Office.	ExoCoBio	ExoCoBio		United States Patent and Trademark Office	11534392	December 27, 2022
	‌ US Patent 11975070 Affinity purification of engineered extracellular vesicles	Patent 11975070 was granted and assigned to Evox Therapeutics on May, 2024 by the United States Patent and Trademark Office.	Evox Therapeutics	Evox Therapeutics		United States Patent and Trademark Office	11975070	May 7, 2024
	‌ US Patent 11850297 Composition comprising sapogenin and exosome as effective ingredient	Patent 11850297 was granted and assigned to ExoCoBio on December, 2023 by the United States Patent and Trademark Office.	ExoCoBio	ExoCoBio		United States Patent and Trademark Office	11850297	December 26, 2023
	‌ US Patent 11690797 Cosmetic composition comprising rose stem cell-derived exosome as effective ingredient		ExoCoBio	ExoCoBio		United States Patent and Trademark Office	11690797	July 4, 2023

8 results

0 selected

8 results

0 selected